Improving type 1 diabetes after treatment of immune thrombocytopenia with rituximab: killing two birds with one stone.
Quintana
Laura
L
Paniagua
Juan A
JA
Gil-Contreras
Daniel
D
Jimenez-Yuste
Victor
V
Torres
Antonio
A
Velasco
Francisco
F
D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000069283:Rituximab; D013921:Thrombocytopenia / Q000188:drug therapy*; D055815:Young Adult
D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab